Correlation Between MegaLong Canadian and InMed Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MegaLong Canadian and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MegaLong Canadian and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MegaLong Canadian Banks and InMed Pharmaceuticals, you can compare the effects of market volatilities on MegaLong Canadian and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MegaLong Canadian with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MegaLong Canadian and InMed Pharmaceuticals.

Diversification Opportunities for MegaLong Canadian and InMed Pharmaceuticals

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between MegaLong and InMed is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding MegaLong Canadian Banks and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and MegaLong Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MegaLong Canadian Banks are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of MegaLong Canadian i.e., MegaLong Canadian and InMed Pharmaceuticals go up and down completely randomly.

Pair Corralation between MegaLong Canadian and InMed Pharmaceuticals

Assuming the 90 days trading horizon MegaLong Canadian Banks is expected to generate 0.4 times more return on investment than InMed Pharmaceuticals. However, MegaLong Canadian Banks is 2.53 times less risky than InMed Pharmaceuticals. It trades about 0.27 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest  2,951  in MegaLong Canadian Banks on September 5, 2025 and sell it today you would earn a total of  1,052  from holding MegaLong Canadian Banks or generate 35.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

MegaLong Canadian Banks  vs.  InMed Pharmaceuticals

 Performance 
       Timeline  
MegaLong Canadian Banks 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MegaLong Canadian Banks are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, MegaLong Canadian displayed solid returns over the last few months and may actually be approaching a breakup point.
InMed Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days InMed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2026. The recent disarray may also be a sign of long period up-swing for the firm investors.

MegaLong Canadian and InMed Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MegaLong Canadian and InMed Pharmaceuticals

The main advantage of trading using opposite MegaLong Canadian and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MegaLong Canadian position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.
The idea behind MegaLong Canadian Banks and InMed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital